May 07, 2009



GlaxoSmithKline (GSK) was among the first foreign pharmaceutical companies to enter India decades ago and is viewed "almost like an Indian company," according to Hasit Joshipura, vice president-south Asia and managing director for GSK in India. During an interview with India Knowledge@Wharton at the recent Wharton India Economic Forum in Philadelphia, Joshipura suggested that GSK's years of experience in India may soon pay significant dividends as it prepares to create a "branded generics portfolio, apart from our own pipeline, in emerging markets." He also spoke about the future of pharmaceutical regulation in India, which he believes will align more closely with Western models in terms of monitoring drug development and new product launches. Read the transcript at: knowledge.wharton.upenn.edu/in...

Category: Education

Tags: Hasit Joshipura GlaxoSmithKline Wharton India Economic Forum drug development new product launch

1. Cricket Legend Sunil Gavaskar: 'The Challenge Is to Get the Team to Believe in Itself'
2. Tata Group's Farrokh Kavarana: 'We Are Just Trying to Reclaim Our Legacy'
3. Tata Sons' David Good: 'We Want to Be Known as a Global Company Rooted in India'
4. Apollo Hospitals' Shobana Kamineni: 'India Is a Nascent Country in Terms of Health Care'
5. ICICI Bank's Chanda Kochhar: 'A Very Exciting and Challenging Journey'
6. GlaxoSmithKline's Hasit Joshipura: Seeing a Healthy Future for India's Pharma Industry
7. Advice from Entrepreneur Sabeer Bhatia: 'Provide the Same Value at a Cheaper Price'
8. Billiards Champion Geet Sethi: 'By the Next Olympics, We Will Win Five Golds'

The Wharton School held the 13th Annual Wharton India Economic Forum on March 21, 2009 in Philadelphia. This event is a leading business forum for thought-leaders, professionals, alumni, faculty and students to discuss the unprecedented opportunities that lie in India's way and the challenges that need to be addressed to realize these opportunities.

Source: Knowledge@Wharton Interviews